NASDAQ Framework: Balchem Corporation
Specialty ingredient manufacturer for health markets 1.
1: Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production, and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey. View Source
Balchem Corporation, incorporated in 1967 and headquartered in Montvale, New Jersey, develops, manufactures, and markets specialty performance ingredients and products for a variety of markets including nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. The company operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients to the food and beverage industry, offering products such as spray dried and emulsified powders, liquid flavor delivery systems, and human grade choline nutrients. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production in animals, as well as nutrient absorption solutions. The Specialty Products segment distributes ethylene oxide and ammonia for healthcare sterilization and markets propylene oxide for fumigation and contamination control in various food products 23.
2: Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, agricultural, and medical sterilization industries. The segments include 1) Human Nutrition and Health segment provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications. 2) The Animal Nutrition and Health segment provide nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride. 3) The Specialty Products segment includes re-packaging and distributing a number of performance gases and chemicals for various uses, notably ethylene oxide, propylene oxide, and ammonia. View Source3: Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production, and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey. View Source
4: Is Balchem Corporation's (NASDAQ:BCPC) Recent Stock Performance Tethered To Its Strong Fundamentals? Most readers would already be aware that Balchem's (NASDAQ:BCPC) stock increased significantly by 19% over the past... Simply Wall St. • 2 days ago BCPC -0.69% Balchem Corporation (BCPC): Is It Among the Most Profitable Stocks of the Last 20 Years? We recently compiled a list of the 20 Most Profitable Stocks of the Last 20 Years. In this article, we are going to take a look at where Balchem Corporation (NASDAQ:BCPC) stands against the other profitable stocks. The stock market has a long history of generating wealth for investors. While past performance doesn’t guarantee future […] Insider Monkey • 4 days ago BCPC -0.69% ^GSPC Balchem Corporation Announces Quarterly Conference Call for Second Quarter Financial Results on July 26, 2024 MONTVALE, N.J., July 12, 2024 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today announced that a conference call will be held on Friday, July 26, 2024, at 11:00 AM Eastern Time (ET) to review second quarter results. Ted Harris, Chairman of the Board, President and CEO, and Martin Bengtsson, CFO, will host the call. Second quarter results will be published prior to the market opening on Friday, July 26, 2024. The press release, and its accompanying financial exhibits, will also be avai GlobeNewswire • 12 days ago BCPC -0.69% Balchem Corporation to Present at the CJS Securities 24th Annual New Ideas Summer Conference on July 10, 2024 MONTVALE, N.J., June 26, 2024 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will present at the CJS Securities 24th Annual New Ideas Summer Conference on July 10, 2024. Ted Harris, Chairman of the Board, President and Chief Executive Officer, Martin Bengtsson, Chief Financial Officer and Allison Baurichter, Senior Director Investor Relations will present at the conference. About Balchem Corporat GlobeNewswire • 28 days ago BCPC -0.69% Why We Think Balchem Corporation's (NASDAQ:BCPC) CEO Compensation Is Not Excessive At All Key Insights Balchem to hold its Annual General Meeting on 20th of June Salary of US$1.16m is part of CEO Ted Harris's... Simply Wall St. • last month BCPC -0.69% Balchem (NASDAQ:BCPC) jumps 3.9% this week, though earnings growth is still tracking behind five-year shareholder returns The main point of investing for the long term is to make money. Furthermore, you'd generally like to see the share... Simply Wall St. • last month BCPC -0.69% Balchem Corporation to Present at the Wells Fargo Industrials Conference on June 12, 2024 MONTVALE, N.J., May 29, 2024 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will present at the Wells Fargo Industrials Conference on June 12, 2024. Ted Harris, Chairman of the Board, President and Chief Executive Officer, Martin Bengtsson, Chief Financial Officer, and Allison Baurichter, Senior Director Investor Relations will present at the conference. About Balchem Corporation Balchem Corporat GlobeNewswire • last month BCPC -0.69% Do Options Traders Know Something About Balchem (BCPC) Stock We Don't? Investors need to pay close attention to Balchem (BCPC) stock based on the movements in the options market lately. Zacks • 2 months ago BCPC -0.69% Balchem Corporation to Attend the Deutsche Bank Global Consumer Conference on June 4, 2024 MONTVALE, N.J., May 21, 2024 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will attend the Deutsche Bank Global Consumer Conference on June 4, 2024. Ted Harris, Chairman of the Board, President and Chief Executive Officer, and Martin Bengtsson, Chief Financial Officer will attend the conference. About Balchem Corporation Balchem Corporation develops, manufactures and markets specialty ingredient GlobeNewswire • 2 months ago BCPC -0.69% Insider Sale at Balchem Corp (BCPC): SVP & Chief Technology Officer Michael Sestrick Sells ... On May 10, 2024, Michael Sestrick, Senior Vice President & Chief Technology Officer of Balchem Corp (NASDAQ:BCPC), sold 1,929 shares of the company. GuruFocus.com • 2 months ago BCPC -0.69% Insider Sale: Director David Fischer Sells 5,000 Shares of Balchem Corp (BCPC) On May 8, 2024, David Fischer, Director at Balchem Corp (NASDAQ:BCPC), executed a sale of 5,000 shares of the company. GuruFocus.com • 2 months ago BCPC -0.69% Balchem Corporation (NASDAQ:BCPC) Q1 2024 Earnings Call Transcript Balchem Corporation (NASDAQ:BCPC) Q1 2024 Earnings Call Transcript May 3, 2024 Balchem Corporation misses on earnings expectations. Reported EPS is $ EPS, expectations were $0.94. Balchem Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings, and welcome to the […] Insider Monkey • 2 months ago BCPC -0.69% Do Balchem's (NASDAQ:BCPC) Earnings Warrant Your Attention? The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even... Simply Wall St. • 2 months ago BCPC -0.69% Balchem First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags Balchem ( NASDAQ:BCPC ) First Quarter 2024 Results Key Financial Results Revenue: US$239.7m (up 3.1% from 1Q 2023). Net... Simply Wall St. • 2 months ago BCPC -0.69% Balchem Corp (BCPC) Q1 2024 Earnings: Surpasses Revenue Expectations and Demonstrates Robust Growth Comprehensive Analysis of Balchem's Financial Performance and Strategic Highlights GuruFocus.com • 2 months ago BCPC -0.69% Balchem Corporation Reports First Quarter 2024 Financial Results MONTVALE, N.J., May 03, 2024 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) reported today financial results for its 2024 fiscal first quarter ended March 31, 2024. The Company reported quarterly net sales of $239.7 million, quarterly net earnings of $29.0 million, adjusted EBITDA(a) of $60.9 million, and free cash flow(a) of $26.8 million. Ted Harris, Chairman, President and CEO of Balchem said, "The first quarter was a very good start to the year for Balchem. We delivered record net sa GlobeNewswire • 2 months ago BCPC -0.69% New York Jets Announce Multi-Year Partnership with VitaCholine® First Professional Sports Partnership for VitaCholine® encompasses rights across regions including the United States and the United Kingdom.MONTVALE, N.J., May 02, 2024 (GLOBE NEWSWIRE) -- The New York Jets announced a partnership with VitaCholine, a Balchem Human Nutrition and Health brand of the essential nutrient choline, as Proud Partner of the team. This agreement marks VitaCholine’s first sponsorship and the first sponsorship in the Nutritional Ingredient category of a major professional s GlobeNewswire • 2 months ago BCPC -0.69% Balchem Corporation to Attend the BMO 19th Annual Global Farm to Market Conference on May 16, 2024 MONTVALE, N.J., May 01, 2024 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will attend the BMO 19th Annual Global Farm to Market Conference on May 16, 2024. Ted Harris, Chairman of the Board, President and Chief Executive Officer, Martin Bengtsson, Chief Financial Officer, and Allison Baurichter, Senior Director Investor Relations will attend the conference. About Balchem Corporation Balchem Cor GlobeNewswire • 2 months ago BCPC -0.69% Balchem Corporation Releases 2023 Sustainability Report MONTVALE, N.J., April 22, 2024 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today published its 2023 Sustainability Report, highlighting the Company's Corporate Social Responsibility initiatives and accomplishments. Guided by our core values and our vision of making the world a healthier place, our Sustainability Report demonstrates the Company's continuing promise to provide our employees, customers, shareholders and the communities within which we operate with information on Balchem’ GlobeNewswire • 3 months ago BCPC -0.69% Balchem Corporation Announces Quarterly Conference Call for First Quarter Financial Results on May 3, 2024 MONTVALE, N.J., April 19, 2024 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today announced that a conference call will be held on Friday, May 3, 2024, at 11:00 AM Eastern Time (ET) to review first quarter results. Ted Harris, Chairman of the Board, President and CEO, and Martin Bengtsson, CFO, will host the call. First quarter results will be published prior to the market opening on Friday, May 3, 2024. The press release, and its accompanying financial exhibits, will also be available GlobeNewswire • 3 months ago BCPC -0.69% View Source5: Balchem Corporation Announces Quarterly Conference Call for Second Quarter Financial Results on July 26, 2024 GlobeNewswire Jul 12, 2024 11:00am Balchem Corporation to Present at the CJS Securities 24th Annual New Ideas Summer Conference on July 10, 2024 GlobeNewswire Jun 26, 2024 11:00am Balchem Corporation to Present at the Wells Fargo Industrials Conference on June 12, 2024 GlobeNewswire May 29, 2024 11:00am Balchem Corporation to Attend the Deutsche Bank Global Consumer Conference on June 4, 2024 GlobeNewswire May 21, 2024 11:00am Balchem Corporation Reports First Quarter 2024 Financial Results GlobeNewswire May 3, 2024 11:00am New York Jets Announce Multi-Year Partnership with VitaCholine® GlobeNewswire May 2, 2024 12:00pm Balchem Corporation to Attend the BMO 19th Annual Global Farm to Market Conference on May 16, 2024 GlobeNewswire May 1, 2024 11:00am View Source
LOW RISK
Balchem Corporation demonstrates a strong financial position with several indicators pointing towards low financial risk. The company has been profitable, as evidenced by its recent earnings reports where it beat both EPS and revenue expectations for Q1 2024 6. Additionally, Balchem has a low three-year median payout ratio of 21%, indicating that it retains a significant portion of its profits for reinvestment 7. The company's consistent dividend payments over at least ten years further underscore its financial stability and commitment to shareholders 8. Overall, these factors suggest that Balchem Corporation is well-positioned to cover its costs and spending plans.
Balchem Corporation demonstrates a strong financial position with several indicators pointing towards low financial risk. The company has been profitable, as evidenced by its recent earnings reports where it beat both EPS and revenue expectations for Q1 2024 6. Additionally, Balchem has a low three-year median payout ratio of 21%, indicating that it retains a significant portion of its profits for reinvestment 7. The company's consistent dividend payments over at least ten years further underscore its financial stability and commitment to shareholders 8. Overall, these factors suggest that Balchem Corporation is well-positioned to cover its costs and spending plans.
6: Balchem reported earnings per share of $1.03. This was above the analyst estimate for EPS of 99 cents.The company reported revenue of $239.66 million.This was 3.10% better than the analyst estimate for revenue of $232.46 million. View Source7: Balchem has a low three-year median payout ratio of 21%, meaning that the company retains the remaining 79% of its profits. This suggests that the management is reinvesting most of the profits to grow the business. View Source8: Besides, Balchem has been paying dividends for at least ten years or more. This shows that the company is committed to sharing profits with its shareholders. View Source
9: Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, agricultural, and medical sterilization industries. The segments include 1) Human Nutrition and Health segment provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications. 2) The Animal Nutrition and Health segment provide nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride. 3) The Specialty Products segment includes re-packaging and distributing a number of performance gases and chemicals for various uses, notably ethylene oxide, propylene oxide, and ammonia. View Source10: Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production, and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey. View Source
Balchem Corporation's product roadmap and expansion strategy for 2024 through to 2026 focuses on leveraging its strong financial position to drive growth across its three primary segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The company plans to continue investing heavily in its business, as evidenced by its low payout ratio, which indicates a significant reinvestment of profits 11. This strategy is expected to support the development and enhancement of its existing product lines, such as human-grade choline nutrients, microencapsulated animal health products, and sterilization chemicals. Additionally, Balchem's ongoing commitment to sustainability and corporate social responsibility, as highlighted in its 2023 Sustainability Report, suggests that the company will prioritize environmentally friendly practices and innovations 1213. Overall, Balchem aims to maintain its market leadership by focusing on organic growth and strategic reinvestments.
11: Balchem has a low three-year median payout ratio of 21%, meaning that the company retains the remaining 79% of its profits. This suggests that the management is reinvesting most of the profits to grow the business. View Source12: Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production, and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey. View Source13: BCPC Stock Earnings: Balchem Beats EPS, Beats Revenue for Q1 2024 View Source